
Max Healthcare Institute Q2 Results FY27: PAT Falls 15.64% to Rs 414.45 Cr, Revenue Rs 2,569.21 Cr
Updated: 30 Oct 2026 • 3:21 pm
Posted by:

Quick Answer
Max Healthcare Institute Q2 Results FY27 were declared on 30 October 2026. On a Consolidated basis, Max Healthcare Institute reported revenue of Rs 2,569.21 Cr, up 20.31% YoY, and net profit of Rs 414.45 Cr, down 15.64% YoY. The Operating Profit stood at Rs 711.49 Cr, up 23.71% YoY. These quarterly results and the YoY growth comparison are explained section by section below.
Max Healthcare Institute Ltd (MAXHEALTH) Q2 Results FY27 announced on 30 October 2026, covering the company’s financial performance for the July to September quarter. The company reported consolidated revenue of Rs 2,569.21 Cr and net profit (PAT) of Rs 414.45 Cr, which is the focus of Max Healthcare Institute Q2 Results FY27. The results date and the consolidated results basis frame every figure that follows, from revenue to profit after tax.
This results analysis of Max Healthcare Institute Q2 Results covers the financial highlights, business drivers, outlook and risks for Max Healthcare Institute. It starts with the Financial Highlights table, which compares the quarter with the same period last year. Each section then builds on the one before it.
Click Here – Get Free Investment Predictions
Max Healthcare Institute Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 2569.21 Cr | Rs 2135.47 Cr | +20.31% YoY |
| Operating Profit | Rs 711.49 Cr | Rs 575.15 Cr | +23.71% YoY |
| Net Profit (PAT) | Rs 414.45 Cr | Rs 491.3 Cr | -15.64% YoY |
Source: company filing for Max Healthcare Institute Q2 Results FY27, 30 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Max Healthcare Institute Q2 Results: What Stands Out
- Revenue: Rs 2,569.21 Cr, up 20.31% YoY from Rs 2,135.47 Cr in the comparable quarter of last year.
- Net profit: Rs 414.45 Cr, down 15.64% YoY from Rs 491.30 Cr, as Max Healthcare Institute Q2 Results FY27 record the PAT change.
- Operating Profit: Rs 711.49 Cr against Rs 575.15 Cr a year earlier, a 23.71% YoY rise.
- YoY growth pattern: Max Healthcare Institute saw revenue rise while net profit fall, so the two lines moved in different directions.
- Next step: the performance analysis below sets out how revenue, profit and the business factors fit together.
Max Healthcare Institute Q2 Results FY27: Performance Analysis
Max Healthcare Institute Q2 Results FY27 show consolidated revenue of Rs 2,569.21 Cr for the July to September 2026 quarter against Rs 2,135.47 Cr a year earlier, a 20.31% YoY rise. Net profit was Rs 414.45 Cr against Rs 491.30 Cr, a 15.64% YoY fall, and the Operating Profit came in at Rs 711.49 Cr against Rs 575.15 Cr.
The Max Healthcare Institute Q2 Results figures also show how profit relates to sales. Net profit equals 16.13% of revenue this quarter against 23.01% in the same quarter last year, so the YoY growth in the two lines can be compared directly. This margin view uses only the reported revenue and net profit.
Investors will follow these numbers in later disclosures, and Max Healthcare Institute Q2 Results FY27 give the base for that comparison. The year-ago quarter had revenue of Rs 2,135.47 Cr and net profit of Rs 491.30 Cr, so each new filing can be read against both levels. That brings the results analysis to the business factors behind these quarterly results.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The quarterly results show revenue of Rs 2,569.21 Cr for Max Healthcare Institute, compared with Rs 2,135.47 Cr in the same quarter last year. That is a 20.31% YoY rise, and it frames how the profit lines should be read.
Sequential Revenue – Revenue was up 8.6% quarter on quarter from Rs 2,366.17 Cr, so the Rs 2,569.21 Cr reported now sits above the preceding quarter as well as above the year-ago figure in the quarterly results.
Operating Profit – The Operating Profit line came in at Rs 711.49 Cr, up 23.71% from Rs 575.15 Cr in the same quarter last year. It links the revenue figure to net profit in the quarterly results. It is part of Max Healthcare Institute Q2 Results FY27.
FY27 Outlook After Max Healthcare Institute Q2 Results
FY27 is still in progress, and Max Healthcare Institute Q2 Results FY27 cover only the second quarter of the financial year. Full-year results for Max Healthcare Institute will depend on how the coming quarters build on this one and on sector conditions disclosed over the year. This results analysis therefore treats the quarter as one input rather than a forecast.
For net profit, the reference points are the Rs 414.45 Cr reported now and the Rs 491.30 Cr of the year-ago quarter. Each later filing will update the YoY comparison, and the Univest Screener tracks every new declaration, while the Univest app shows the updated figures when they arrive. The risks below show which supplied data points deserve the closest attention.
Key Risks to Watch After Max Healthcare Institute Q2 Results FY27
Net Profit Decline
In Max Healthcare Institute Q2 Results FY27, net profit fell 15.64% YoY to Rs 414.45 Cr from Rs 491.30 Cr. The lower profit base is the first figure to track, since each later year-on-year reading will start from it.
Margin Compression
Net profit margin narrowed to 16.1% from 23.0% in the comparison quarter. A thinner margin means a smaller share of each rupee of revenue reached net profit, a point the YoY growth figures bring into focus.
Return on Equity
Return on equity of 14.53% in FY26 is below 15%. This annual ratio stays on the watch list, and later quarters will show whether the year-on-year narrows that gap.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Max Healthcare Institute Q2 Results FY27 record revenue of Rs 2,569.21 Cr and net profit of Rs 414.45 Cr in the consolidated results. Revenue moved up 20.31% and net profit moved down 15.64% on a YoY basis, as the quarterly results show. Later filings will show how the Max Healthcare Institute Q2 Results figures carry forward. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Max Healthcare Institute Q2 Results FY27
What are Max Healthcare Institute Q2 Results FY27?
Ans. Max Healthcare Institute Q2 Results FY27 are the quarterly results the company declared on 30 October 2026. Alongside this, revenue was Rs 2,569.21 Cr and net profit Rs 414.45 Cr, as set out in the Financial Highlights section.
What is the results date for Max Healthcare Institute Q2 Results FY27?
Ans. Max Healthcare Institute declared the results on 30 October 2026, the results date for the July to September 2026 quarter. This means every figure in the Financial Highlights section reflects the filing made on that day.
What revenue was reported in Max Healthcare Institute Q2 Results FY27?
Ans. Max Healthcare Institute Q2 Results FY27 show revenue of Rs 2,569.21 Cr, a 20.31% YoY rise. Compared with Rs 2,135.47 Cr a year earlier, this is the top line movement discussed in the Performance Analysis section.
What net profit was reported in Max Healthcare Institute Q2 Results FY27?
Ans. Max Healthcare Institute reported net profit of Rs 414.45 Cr for the quarter. Alongside this, the year-ago figure was Rs 491.30 Cr, and the Key Takeaways section sets the two side by side.
How much YoY growth did revenue show in Max Healthcare Institute Q2 Results FY27?
Ans. Revenue showed a 20.31% YoY rise in Max Healthcare Institute Q2 Results FY27, moving from Rs 2,135.47 Cr to Rs 2,569.21 Cr. This means the YoY growth view in the Performance Analysis section starts from Rs 2,569.21 Cr.
Did net profit rise or fall in Max Healthcare Institute Q2 Results?
Ans. Max Healthcare Institute Q2 Results show net profit fell 15.64% YoY, from Rs 491.30 Cr to Rs 414.45 Cr. Alongside this, revenue moved up 20.31%, as explained in the Performance Analysis section.
What was the Operating Profit in Max Healthcare Institute Q2 Results FY27?
Ans. Max Healthcare Institute Q2 Results FY27 show Operating Profit of Rs 711.49 Cr, up 23.71% YoY from Rs 575.15 Cr. This line sits between revenue and net profit, as shown in the Key Takeaways section.
Are Max Healthcare Institute Q2 Results consolidated results or standalone results?
Ans. Max Healthcare Institute Q2 Results are consolidated results, so every revenue and profit figure uses the consolidated basis. This means the Financial Highlights section compares like with like for both quarters.
What business factors shaped Max Healthcare Institute Q2 Results FY27?
Ans. Max Healthcare Institute Q2 Results FY27 were shaped by the business factors supplied for the quarter, including revenue growth and sequential revenue. So the Key Business Factors section sets out each factor with the reported figures.
What are the key risks after Max Healthcare Institute Q2 Results FY27?
Ans. The key risks after Max Healthcare Institute Q2 Results FY27 are net profit decline, margin compression and return on equity. Alongside this, each risk is explained with its reported figures in the Key Risks to Watch section.
What is the outlook after Max Healthcare Institute Q2 Results?
Ans. Max Healthcare Institute Q2 Results sit in a financial year that is still in progress, so FY27 full-year results will depend on later quarters. This means the Outlook section treats the quarter as one input, not a forecast.
Where can I find the complete Max Healthcare Institute Q2 Results FY27 data?
Ans. The complete Max Healthcare Institute Q2 Results FY27 data sits in the Financial Highlights table and on the Univest stock page. So readers can compare the figures with later filings.
Recent Articles

Vadilal Industries Q2 Results FY27: PAT Jumps 64.03% to Rs 54.82 Cr, Revenue Rs 462.56 Cr
30 October 2026

SJVN Q2 Results FY27: Profit Rises 113.68%, Revenue Rs 2,244.32 Cr, PAT Rs 657.72 Cr
30 October 2026

GAIL Q2 Results FY27: Profit Rises 135.76%, Revenue Rs 45,923.57 Cr, PAT Rs 4,650.22 Cr
30 October 2026

Sudarshan Pharma Share Price Reverses From Rs 39 to Rs 36.42 on 30 October 2026 as Profit Booking Follows 86% Profit Jump in Sudarshan Pharma Q2 Results: Will the Small-Cap Pharma Stock Rebound?
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Vadilal Industries Q2 Results FY27: PAT Jumps 64.03% to Rs 54.82 Cr, Revenue Rs 462.56 Cr
SJVN Q2 Results FY27: Profit Rises 113.68%, Revenue Rs 2,244.32 Cr, PAT Rs 657.72 Cr
GAIL Q2 Results FY27: Profit Rises 135.76%, Revenue Rs 45,923.57 Cr, PAT Rs 4,650.22 Cr
Sudarshan Pharma Share Price Reverses From Rs 39 to Rs 36.42 on 30 October 2026 as Profit Booking Follows 86% Profit Jump in Sudarshan Pharma Q2 Results: Will the Small-Cap Pharma Stock Rebound?
Trent Share Price Jumps 5.44% to Rs 3,017 on 30 October 2026 as Trent Q2 Results Show 25% Profit Growth and 120 bps Gross Margin Gain: Can Trent Stock Sustain the Momentum?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





